Propelling cancer treatment forward by leaps and bounds requires high-risk innovations that challenge traditional boundaries. This is why ACGT funds research that has never been done before.
Learn MoreCell and gene therapies are saving the lives of people with otherwise deadly forms of advanced cancer, but the progress to date represents just the tip of a potential iceberg for a field that has generated so much hope for patients.
Learn MoreACGT 2020 Research Awards – RFA is now open. Deadline for LOI submission is December 3rd, 2019. This award is for solid tumor research with preference given to glioblastoma and pancreatic cancers.
Learn More